Damian joined Ebb in 2012 and has fifteen years of financial leadership experience in both public and private life sciences companies. Damian was the Corporate Controller for Respironics, a global leader in the sleep and respiratory markets that was acquired by Philips for $5B in 2008. After the acquisition, he was Controller for Philips’ Home Healthcare business and led the global finance integration. Prior to Respironics, Damian spent seven years in public accounting at Ernst & Young.
Share this post